Myopia management is a set of clinical strategies designed to slow the worsening of nearsightedness in children, not just correct it. Standard glasses and contact lenses sharpen a child’s vision but do nothing to prevent the eye from continuing to grow longer, which is what drives myopia progression. Myopia management uses specialized lenses, eye drops, and lifestyle changes to put the brakes on that growth, reducing the risk of serious eye problems later in life.
Why Correcting Vision Isn’t Enough
Nearsightedness happens when the eyeball grows too long from front to back. Light entering the eye focuses in front of the retina instead of directly on it, making distant objects blurry. Regular glasses fix the blur, but the eye keeps elongating. Every additional millimeter of length pushes the prescription higher and stretches the retina thinner, like inflating a balloon.
That stretching is the real concern. High myopia, defined as a prescription of -6.00 diopters or stronger, significantly raises the lifetime risk of retinal detachment, glaucoma, cataracts, and a form of irreversible vision loss called myopic macular degeneration. These aren’t rare complications in high myopia. The goal of myopia management is to keep a child’s prescription as low as possible by the time their eyes stop growing, typically in their late teens or early twenties.
The urgency is growing. In 2010, roughly 27% of the world’s population was myopic. By 2050, that figure is projected to reach 52%, nearly 5 billion people, with 10% expected to have high myopia. More children are becoming nearsighted at younger ages, giving the condition more years to progress before growth stabilizes.
Who Should Start and When
Current treatment approaches have been studied in children from ages 4 to 16, and clinical guidelines recommend this window for intervention. The single most important trigger for starting myopia management is documented progression of at least -0.50 diopters per year. An eye care provider confirms this by comparing current and past prescriptions or by measuring axial length (the front-to-back measurement of the eye) over time.
Several factors push clinicians toward earlier, more proactive treatment. Children who become nearsighted before age 10 tend to progress faster and reach higher prescriptions. Having one or both parents with myopia increases a child’s risk substantially. If a child has minimal myopia, no family history, and no evidence of progression, monitoring with regular exams is a reasonable approach, but watchful waiting should include periodic measurements so progression isn’t missed.
Low-Dose Atropine Eye Drops
Atropine is a medication traditionally used to dilate the pupil, but at very low concentrations it slows myopia progression through a mechanism researchers are still working to fully understand. The drops are administered once daily, usually at bedtime, and children typically use them for two or more years.
Three concentrations are commonly studied: 0.01%, 0.025%, and 0.05%. Higher concentrations slow progression more effectively. In a large network analysis of Asian children, 0.05% atropine reduced eye elongation by 0.27 mm per year compared to placebo, while 0.01% reduced it by 0.13 mm per year. The 0.025% concentration fell in between at 0.20 mm per year of reduced growth.
Side effects are generally mild. The most common complaints are light sensitivity, glare, and slight blurring of near vision, reported in about 18% of children using concentrations between 0.01% and 0.5%. Lower concentrations cause fewer of these issues, which is why many practitioners start at 0.01% or 0.025% and adjust based on response. Some children experience a rebound effect, where progression accelerates temporarily after stopping the drops, so tapering off gradually is standard practice.
Orthokeratology (Overnight Lenses)
Orthokeratology, or ortho-K, uses rigid gas-permeable contact lenses worn only during sleep. The lenses gently reshape the front surface of the cornea overnight so the child sees clearly during the day without glasses or contacts. Beyond the convenience factor, ortho-K lenses alter how light focuses on the peripheral retina, which appears to send signals that slow eye growth.
The results are striking. In a recent study, children wearing standard ortho-K lenses experienced 53% less eye elongation over 12 months compared to children in regular glasses. A modified design with a smaller optical zone achieved a 78% reduction. These numbers make ortho-K one of the more effective single interventions available.
The lenses require careful fitting by a specialist and diligent hygiene to prevent eye infections. Children need to be responsible enough (or have parents willing) to handle nightly insertion and removal, proper cleaning, and regular follow-up visits. Most practitioners recommend ortho-K for children around age 8 and older, though younger children can be fitted when the clinical situation warrants it.
Specialized Daytime Contact Lenses
Dual-focus soft contact lenses, the most studied being the MiSight lens, are daily disposable contacts designed for children. They correct central vision normally while simultaneously creating a specific pattern of defocus in the peripheral visual field. This peripheral signal is thought to discourage the eye from elongating.
Over six years of clinical follow-up, children wearing MiSight lenses accumulated 52% to 67% less myopia progression than untreated children. Daily disposables carry a lower infection risk than overnight lenses because there’s no cleaning or storage involved. Each pair is worn once and discarded. Children as young as 8 have been successfully fitted, and most adapt within the first week.
Myopia-Control Spectacle Lenses
For children who aren’t candidates for contact lenses or eye drops, specially engineered glasses offer another option. These look like ordinary lenses but contain microscopic structures, either multiple tiny segments or aspherical lenslets, that create controlled defocus across the retina.
Two major designs dominate the market. DIMS (Defocus Incorporated Multiple Segments) lenses reduced eye elongation to 0.098 mm per year compared to 0.193 mm per year in standard single-vision glasses in a real-world comparison. HALT (Highly Aspherical Lenslet Target) lenses performed even better, slowing elongation to just 0.054 mm per year. HALT lenses were statistically superior to DIMS in head-to-head analysis. Both designs cut prescription progression by roughly 70% to 80% compared to regular glasses.
These lenses have the advantage of being the simplest option. There are no drops to remember, no contact lens hygiene to manage, and no age-related concerns about lens handling. The tradeoff is that compliance depends entirely on the child wearing the glasses consistently throughout the day.
The Role of Outdoor Time
Time spent outdoors is the most accessible protective factor against developing myopia in the first place. Bright natural light stimulates the release of a chemical in the retina that appears to regulate eye growth. Indoor light, even in well-lit rooms, is not intense enough to produce the same effect.
Research supports a minimum of one hour per day of outdoor time for children, with more time providing greater benefit. This doesn’t need to involve sports or exercise. Walking, playing, or simply being outside during recess counts. Some schools in high-myopia regions of East Asia have adopted policies requiring outdoor recess, designing classrooms with large windows, and organizing outdoor programs specifically to address myopia prevention.
Outdoor time is most effective at delaying the onset of myopia in children who aren’t yet nearsighted. Once myopia has developed, outdoor time alone isn’t sufficient to control progression, but it remains a useful complement to other treatments.
Combining Treatments
Many eye care providers use more than one approach simultaneously. A common combination is low-dose atropine drops paired with ortho-K lenses or myopia-control spectacles. The rationale is that each treatment works through a somewhat different mechanism, so combining them may produce a greater cumulative slowdown than either alone. Early evidence supports this approach, though optimal combinations are still being refined in clinical practice.
Treatment is not one-size-fits-all. The best approach depends on the child’s age, rate of progression, prescription level, lifestyle, and family preferences. A child who plays water sports might do better with atropine drops and myopia-control glasses than with contact lenses. A teenager who refuses to wear glasses might thrive with ortho-K. Regular monitoring, typically every six months, allows practitioners to track whether the chosen strategy is working and adjust if progression continues faster than expected.